Frontline Multiple Myeloma Management: A Clinical and Cost Update for Managed Care

Slide Lecture with Audio

Sponsored by North American Center for Continuing Medical Education, LLC

Presenter/Q&A Cohost

Paul G. Richardson, MD
Associate Professor of Medicine, Harvard Medical School
Clinical Director, Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
Boston, Massachusetts

Q&A Cohost

William J. Cardarelli, PharmD
Director of Pharmacy
Atrius Health
Harvard Vanguard Medical Associates
Watertown, Massachusetts

Target Audience

This activity is designed for managed care professionals including medical directors, pharmacy directors, formulary directors, and other managed care physicians, and pharmacists.

Learning Objectives

After completing this activity, participants should be able to:

Interpret and apply recent safety, efficacy, and cost data on available and emerging transplantation and pharmacologic treatment modalities for frontline multiple myeloma management
Chart the total costs of multiple myeloma treatment, including the management of comorbidities and adverse effects of therapy
Describe the potential impact of genetic testing on clinical outcomes and cost savings
Promote evidence-based and guideline-directed frontline multiple myeloma management practices among in-plan oncologists to optimize outcomes

Activity Overview

The on-demand slide lecture with audio is available with html slides and the presentation transcript. To be eligible for documentation of credit, participants must participate in the full activity, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. Participants who successfully complete the post-test and evaluation form online at www.naccme.com, may immediately print their documentation of credit.

There is no fee associated with this activity.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.

This educational activity is a knowledge-based activity

Release Date: April 16, 2010

Expiration Date: May 12, 2011

Estimated time to complete: 1 hour

For questions regarding this activity, please call 609-371-1137.

All educational activities are accessible via a computer with 650 MHz PC, 128 MB RAM, Windows or MAC operating system, Internet Explorer, Netscape or Safari browsers. Windows Media Player, sound card, and speakers are required for streamed audio. Flash Player, sound card, and speakers are required for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

CME Accreditation

North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

NACCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CPE Accreditation

North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 1 contact hour (0.1 CEU) of continuing pharmacy education (UAN 276-000-10-012-H01-P).

Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity accredited by NACCME may contact John Savage, Director, Medical Education, NACCME, in writing at 300 Rike Drive, Suite A, Millstone Township, NJ 08535, or by e-mail at jsavage@naccme.com. The Director of Medical Education will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Vice President, Medical Education, NACCME, may be made for a second level of review.

Independent Clinical Reviewer: Don M. Benson, Jr, MD, PhD, Assistant Professor of Medicine, Division of Hematology/Oncology, Co-Medical Director, Cell Therapy Laboratory, Blood and Marrow Transplant Program, James Cancer Hospital & Solove Research Institute, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.

Planning Committee

The planning committee comprises, Don Benson, Jr., MD; William Cardarelli, PharmD; Paul Richardson, MD; Mike Kearney, Donna Kruggel, Emilie McCardell, Nick Lombardi, Randy Robbin, and John Savage, NACCME.

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:
Dr. Benson: Grant/Research Support—American Society of Clinical Oncology, Ohio State University; Nationwide Children’s Hospital Research Foundation; Multiple Myeloma Research Foundation
Dr. Cardarelli: Has disclosed no relevant final relationships with any commercial interests
Dr. Richardson: Grant/Research Support—Millennium Pharmaceuticals, Inc; Scientific Advisor—Millennium Pharmaceuticals, Celgene, Johnson & Johnson

Mr. Kearney, Ms. Kruggel, Ms. McCardell, Mr. Robbin, and Mr. Savage have disclosed no relevant financial relationships with any commercial interests.

Mr. Lombardi: Stock Shareholder—Inspire Pharmaceuticals, Viro Pharmaceuticals, Vertex Pharmaceuticals, Inc.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty has disclosed that no off-label/unapproved use(s) of drugs and/or devices will be discussed.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2010 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education, LLC.

Grant Support

Supported by an educational grant from Millennium Pharmaceuticals, Inc